Cubist Systematic Strategies, LLC Fate Therapeutics Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $296,245 - $707,399	179,543 Added 515.9%	214,345 $801,000
Q3 2023 Nov 14, 2023	SELL	$2.02 - $5.04 $848,672 - $2.12 Million	-420,135 Reduced 92.35%	34,802 $73,000
Q2 2023 Aug 14, 2023	SELL	$4.76 - $6.59 $895,746 - $1.24 Million	-188,182 Reduced 29.26%	454,937 $2.17 Million
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $299,216 - $784,738	70,570 Added 12.33%	643,119 $3.67 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $3.1 Million - $7.48 Million	313,923 Added 121.38%	572,549 $5.78 Million
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $2.28 Million - $3.91 Million	-108,436 Reduced 29.54%	258,626 $5.8 Million
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $6.22 Million - $14.8 Million	350,056 Added 2058.43%	367,062 $9.1 Million
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $190,184 - $386,394	6,410 Added 60.49%	17,006 $659,000
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $3.37 Million - $4.53 Million	-70,438 Reduced 86.92%	10,596 $620,000
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $3.69 Million - $5.96 Million	62,238 Added 331.12%	81,034 $4.8 Million
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $1.63 Million - $2.25 Million	-24,283 Reduced 56.37%	18,796 $1.63 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $2.04 Million - $3.32 Million	-28,281 Reduced 39.63%	43,079 $3.55 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $575,616 - $1.53 Million	-15,112 Reduced 17.48%	71,360 $6.49 Million
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $2.63 Million - $3.5 Million	86,372 Added 86372.0%	86,472 $3.46 Million
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $2,021 - $3,522	100 New	100 $3,000
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $764,069 - $1.41 Million	-44,217 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $591,998 - $916,514	44,212 Added 884240.0%	44,217 $865,000
Q3 2019 Nov 14, 2019	SELL	$15.47 - $22.5 $76,468 - $111,217	-4,943 Reduced 99.9%	5 $0
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $32,562 - $42,637	2,086 Added 72.89%	4,948 $100,000
Q1 2019 May 15, 2019	SELL	$13.15 - $18.71 $241,999 - $344,320	-18,403 Reduced 86.54%	2,862 $50,000
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $244,122 - $361,079	21,265 New	21,265 $273,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$21.3 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$16.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$16.4 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$9.03 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$8.51 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $157M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account